1.72
Matinas Biopharma Holdings Inc stock is traded at $1.72, with a volume of 49,235.
It is up +1.78% in the last 24 hours and up +84.95% over the past month.
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. The company enables the delivery of life-changing medicines using its lipid nano-crystal (LNC) platform technology. Its LNC delivery technology platform utilizes lipid nano-crystals which can encapsulate small molecules, oligonucleotides, vaccines, peptides, proteins and other medicines potentially making them safer, more tolerable, less toxic, and orally bioavailable. The company's lead anti-fungal product candidate is MAT2203, an orally-administered cochleate formulation of amphotericin B that has completed Phase II clinical trials for the prevention of invasive fungal infections due to immunosuppressive therapy in patients with acute lymphoblastic leukemia. Its product candidates also comprise MAT2501, an orally administered cochleate formulation of the broad spectrum aminoglycoside antibiotic amikacin that has completed Phase I clinical trials to treat various types of multidrug-resistant bacteria, including non-tuberculous mycobacterium infections, as well as various multidrug-resistant gram negative and intracellular bacterial infections. The company was founded in 2013 and is based in Bedminster, New Jersey.
See More
Previous Close:
$1.69
Open:
$1.69
24h Volume:
49,235
Relative Volume:
0.08
Market Cap:
$8.75M
Revenue:
-
Net Income/Loss:
$-21.13M
P/E Ratio:
-0.3591
EPS:
-4.79
Net Cash Flow:
$-16.95M
1W Performance:
-5.49%
1M Performance:
+84.95%
6M Performance:
+214.27%
1Y Performance:
-52.75%
Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile
Name
Matinas Biopharma Holdings Inc
Sector
Industry
Phone
908-443-1860
Address
1545 Route 206 South, Suite 302, Bedminster, NJ
Compare MTNB with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
MTNB
Matinas Biopharma Holdings Inc
|
1.72 | 9.39M | 0 | -21.13M | -16.95M | -4.79 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
May-11-21 | Downgrade | Piper Sandler | Overweight → Neutral |
Aug-26-20 | Resumed | Piper Sandler | Overweight |
Jan-27-20 | Initiated | Piper Sandler | Overweight |
Jan-24-20 | Initiated | SunTrust | Buy |
Jan-23-20 | Initiated | SunTrust | Buy |
Jan-09-20 | Initiated | Aegis Capital | Buy |
Jun-26-19 | Initiated | H.C. Wainwright | Buy |
View All
Matinas Biopharma Holdings Inc Stock (MTNB) Latest News
How to recover losses in Matinas BioPharma Holdings Inc. stockBull Run & Smart Allocation Stock Tips - Newser
Chart based analysis of Matinas BioPharma Holdings Inc. trendsJuly 2025 EndofMonth & Low Drawdown Momentum Ideas - Newser
News impact scoring models applied to Matinas BioPharma Holdings Inc.Quarterly Trade Report & Weekly Setup with High ROI Potential - Newser
Can Matinas BioPharma Holdings Inc. reach all time highs this year2025 Stock Rankings & Reliable Entry Point Trade Alerts - خودرو بانک
How does Matinas BioPharma Holdings Inc. compare to its peers2025 Macro Impact & Low Risk High Win Rate Stock Picks - خودرو بانک
Real time alert setup for Matinas BioPharma Holdings Inc. performance2025 Short Interest & Community Consensus Picks - Newser
Applying chart zones and confluence areas to Matinas BioPharma Holdings Inc.July 2025 Levels & Reliable Breakout Forecasts - Newser
Visual trend scoring systems applied to Matinas BioPharma Holdings Inc.July 2025 Market Mood & Safe Entry Trade Reports - Newser
Is a relief rally coming for Matinas BioPharma Holdings Inc. holdersDollar Strength & Long-Term Growth Portfolio Plans - Newser
What is the target price for Matinas BioPharma Holdings Inc. stockJuly 2025 Trade Ideas & AI Forecasted Entry/Exit Points - 강소기업뉴스
Applying Wyckoff theory to Matinas BioPharma Holdings Inc. stockJuly 2025 Decliners & Growth Oriented Trading Recommendations - Newser
What’s the beta of Matinas BioPharma Holdings Inc. stockJuly 2025 Earnings & Weekly High Potential Alerts - خودرو بانک
Is Matinas BioPharma Holdings Inc. forming higher highs and higher lowsQuarterly Profit Summary & Technical Entry and Exit Alerts - خودرو بانک
Custom watchlist performance reports with Matinas BioPharma Holdings Inc.Earnings Recap Report & Advanced Swing Trade Entry Alerts - Newser
Does Matinas BioPharma Holdings Inc. show high probability of reboundRate Cut & Free Fast Gain Swing Trade Alerts - Newser
Is this a good reentry point in Matinas BioPharma Holdings Inc.July 2025 Action & Momentum Based Trading Ideas - Newser
Heatmap analysis for Matinas BioPharma Holdings Inc. and competitors2025 Trading Volume Trends & Entry Point Confirmation Signals - Newser
Can you recover from losses in Matinas BioPharma Holdings Inc.Volume Spike & Real-Time Stock Price Movement Reports - Newser
What institutional flow reveals about Matinas BioPharma Holdings Inc.Weekly Investment Summary & Community Consensus Stock Picks - Newser
Is Matinas BioPharma Holdings Inc. exposed to currency risksPortfolio Value Report & Expert-Curated Trade Recommendations - خودرو بانک
What does recent volatility data suggest for Matinas BioPharma Holdings Inc.Quarterly Growth Report & Community Verified Trade Signals - Newser
Is Matinas BioPharma Holdings Inc. exposed to political risk2025 Sector Review & Technical Pattern Based Signals - خودرو بانک
Can machine learning forecast Matinas BioPharma Holdings Inc. recovery2025 EndofYear Setup & Free High Return Stock Watch Alerts - Newser
Will Matinas BioPharma Holdings Inc. see short term momentumWeekly Profit Recap & Weekly Breakout Watchlists - Newser
Is Matinas BioPharma Holdings Inc. stock influenced by commodity pricesPortfolio Gains Report & Weekly High Return Stock Forecasts - خودرو بانک
Combining price and volume data for Matinas BioPharma Holdings Inc.July 2025 Earnings & Capital Efficiency Focused Ideas - Newser
Price momentum metrics for Matinas BioPharma Holdings Inc. explainedAnalyst Upgrade & Stepwise Trade Execution Plans - Newser
Institution Moves: Should I invest in Israel Acquisitions Corp before earningsJuly 2025 Earnings & Free Growth Oriented Trading Recommendations - khodrobank.com
Will Matinas BioPharma Holdings Inc. benefit from current market trendsCEO Change & AI Driven Stock Price Forecasts - خودرو بانک
Weekly Trades: Will Matinas BioPharma Holdings Inc. announce a stock splitPortfolio Performance Summary & Accurate Intraday Trading Signals - خودرو بانک
Does Matinas BioPharma Holdings Inc. outperform in volatile marketsWeekly Investment Recap & Reliable Volume Spike Trade Alerts - خودرو بانک
Matinas BioPharma Holdings Inc. stock trend forecastJuly 2025 Short Interest & Weekly Stock Performance Updates - Newser
Analyzing Matinas BioPharma Holdings Inc. with multi timeframe chartsMarket Trend Review & Weekly Momentum Stock Picks - Newser
Can bioAffinity Technologies Inc. sustain earnings growthMarket Risk Analysis & Fast Exit and Entry Trade Guides - khodrobank.com
Will a bounce in Matinas BioPharma Holdings Inc. offer an exit2025 Trading Recap & Intraday High Probability Alerts - Newser
Is Matinas BioPharma Holdings Inc. a play on infrastructure spendingGlobal Markets & Entry Point Strategy Guides - خودرو بانک
Matinas BioPharma Holdings Inc. Shows Early Signs of Technical Strength2025 Big Picture & Stepwise Entry and Exit Trade Signals - 선데이타임즈
Published on: 2025-09-02 04:49:25 - خودرو بانک
Can Northern Technologies International Corporation outperform under higher oil prices2025 Investor Takeaways & Safe Swing Trade Setup Alerts - khodrobank.com
Matinas BioPharma Holdings Inc. Moves Into Overbought Range Analysts Cautious getLinesFromResByArray error: size == 0 - thegnnews.com
Matinas BioPharma plunges as deal for lead asset falls apart - MSN
Technical Bounce Expected in Matinas BioPharma Holdings Inc. Next Week getLinesFromResByArray error: size == 0 - kangso.co.kr
Matinas Biopharma Holdings Inc Stock (MTNB) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):